Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 49, Issue 3, 2000, Pages 211-218

  Jenning, Volkhard ^a   Gysler, Anja ^a   Schäfer Korting, Monika ^a   Gohla, Sven H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Drug localization in the skin; Percutaneous absorption; Porcine skin; Solid lipid nanoparticles; Vitamin A

Indexed keywords

BEHENIC ACID GLYCEROL ESTER; GLYCEROL BEHENATE; GLYCEROL DERIVATIVE; MIGLYOL; NANOPARTICLE; RETINOL; RETINOL PALMITATE; UNCLASSIFIED DRUG; WATER OIL CREAM; XANTHAN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; SKIN PENETRATION; SWINE; WATER LOSS;

ADMINISTRATION, TOPICAL; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMULSIONS; EXCIPIENTS; FATTY ACIDS; HYDROGELS; MICROSPHERES; OCCLUSIVE DRESSINGS; PARTICLE SIZE; SKIN; SKIN ABSORPTION; SWINE; VITAMIN A; WATER LOSS, INSENSIBLE;

EID: 0034595218     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(99)00075-2     Document Type: Article

References (37)

1. Müller R.H., Mehnert W., Lucks J.S., Schwarz C., zur Mühlen A., Weyhers H., Freitas C., Rühl D. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:1995;62-69.
2. Schwarz C., Mehnert W., Müller R.H. Influence of production parameters of solid lipid nanoparticles (SLN) on the suitability for intravenous injection. Eur. J. Pharm. Biopharm. 40:1994;24S.
3. Heiati H., Tawash R., Phillips N.C. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencapsul. 15:1998;173-184.
4. Domb A.J. Liposphere parenteral delivery systems. Proc. Int. Symp. Control. Rel. Bioact. Mater. 20:1993;121-122.
5. Siekmann B., Westesen K. Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1:1992;123-126.
6. Müller R.H., Dingler A. The next generation after the liposomes: solid lipid nanoparticles (SLN/Lipopearls) as dermal carrier in cosmetics. Euro Cosmet. 7/8:1998;19-26.
7. Almeida A.J., Runge S.A., Müller R.H. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int. J. Pharm. 136:1996;155-163.
8. S.A. Runge, Feste Lipid Nanopartikel (SLN) als kolloidaler Arzneistoffträger für die orale Applikation von Ciclosporin A, Ph.D. thesis, FU Berlin, 1998.
9. Müller R.H., Maaßen S., Weyhers H., Specht F., Lucks J.S. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int. J. Pharm. 138:1996;85-94.
10. Eury R., Patel R., Longe K., Cheng T., Nacht S. Controlled release subdued. Chemtech. 22:1992;42-46.
11. Wester R., Patel R., Nacht S., Leyden J., Melendres J., Maibach H. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol. 24:1991;720-726.
12. Masini V., Bonte F., Meybeck A., Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J. Pharm. Sci. 82:(1):1993;17-21.
13. Schäfer-Korting M., Korting H.C., Ponce-Pöschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Invest. 72:1994;1086-1091.
14. Embil K., Nacht S. The microsponge delivery system: a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J. Microencapsul. 5:1996;575-588.
15. Schütt D.H., Kaiser E., Stamm I., Kubis A., Müller R.H. 85 New generation of cosmetic products based on solid lipid nanoparticles (lipoperls). 1998;585-586 Proceedings of the 2nd World Meeting APGI/APV, Paris, France.
16. De Vringer T., de Ronde H.A.G. Preparation and structure of a water-in-oil cream containing lipid nanoparticles. J. Pharm. Sci. 84:1995;466-472.
17. Nangia A., Patil S., Berner B., Boman A., Maibach H. In vitro measurements of transepidermal water loss: a rapid alternative to tritiated water permeation for assessing skin barrier function. Int. J. Pharm. 170:1998;33-40.
18. Duell E.A., Kang S., Voorhees J.J. Unoccluded retinol penetrates human skin in vivo more effectively than unoccluded retinyl palmitate or retinoic acid. J. Invest. Dermatol. 109:1997;301-305.
19. R.H. Müller, J.S. Lucks, Arzneistoffträger aus festen Lipidteilchen - Feste Lipid Nanosphären (SLN), European patent application EP 0 605 497 B1 (1996).
20. Reifenrath W.G., Hawkins G.S., Kurtz M.S. Percutanous penetration and skin retention of topically applied compounds: an in vitro-in vivo study. J. Pharm. Sci. 80:1991;526-532.
21. Touitou E., Meidan V.M., Horwitz E. Methods for quantitative determination of drug localized in the skin. J. Control. Rel. 56:1998;7-21.
22. Meyer W., Schwarz R., Neurand K. The skin of domestic mammals as a model for human skin with special reference to the domestic pig. Curr. Probl. Dermatol. 7:1978;39-52.
23. Neubert R., Wohlrab W. In vitro methods for the biopharmaceutical evaluation of topical formulations. Acta Pharm. Technol. 36:1990;197-206.
24. Potts R.O. Physical characterization of the stratum corneum: the relationship of mechanical and barrier properties of lipid and protein structure. Hadgraft J., Guy R.H. Transdermal Drug Delivery. 1989;23-57 Marcel Dekker, New York.
25. Freitas C., Müller R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47:1999;125-132.
26. V. Jenning, M. Schäfer-Korting, S. Gohla, Vitamin A loaded solid lipid nanoparticles for topical use: drug release properties, J. Control. Rel. (2000) in press.
27. Duell E.A., Derguini F., Kang S., Elder J.T., Vorhees J.J. Extraction of human epidermis treated with retinol yields retro-retinoids in addition to free retinol and retinyl esters. J. Invest. Dermatol. 107:1996;178-182.
28. T. de Vringer, Topical preparation containing a suspension of solid lipid particles, European Patent Application EP 0 506 197 A1 (1992).
29. Rössler B., Kreuter J., Ross G. Effect of collagen microparticles on the stability of retinol and its absorbtion into hairless mouse skin in vitro. Pharmazie. 49:1994;175-179.
30. Cooper E.G., Patel D.C. Practical considerations for topical drug formulations with and without enhancers. Osborne D.W., Amann A.H. Topical Drug Delivery Formulations. 1990;1-12 Marcel Dekker, New York.
31. Gummer C.L. The in vitro evaluation of transdermal delivery. Hadgraft J., Guy R.H. Transdermal Drug Delivery. 1989;150-166 Marcel Dekker, New York.
32. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Hadgraft J., Guy R.H. Transdermal Drug Delivery. 1989;197-246 Marcel Dekker, New York.
33. Korting H.C., Schäfer-Korting M. Topical liposome drugs. Korting H.C., Schäfer-Korting M. The Benefit/ Risk Ratio. A Handbook for Rational Use of Potentially Hazardous Drugs. 1998;333-352 CRC Press, Boca Raton, FL.
34. Schäfer-Korting M., Gysler A. Topical glucocorticoids with improved risk-benefit ratio. Korting H.C., Schäfer-Korting M. The Benefit/Risk Ratio. A Handbook for Rational Use of Potentially Hazardous Drugs. 1998;361-373 CRC Press, Boca Raton, FL.
35. Bennat C., Müller-Goymann C.C. Characterization of skin penetration of microfine titanium dioxide used in sunscreen formulations. 1998;859-860 Proceedings of the 2nd World Meeting APGI/APV, Paris, France.
36. Wolter K., Schaefer H., Frömming K.H., Stüttgen G. Partikelgröβe und Permeation. Seifen Fette Anstrichmittel. 11:1970;990-993.
37. Kang S., Duell E.A., Fisher G.J., Datta S.C., Wang Z.Q., Reddy A.P., Tavakkol A., Yi J.Y., Griffiths C.E.M., Elder J.T., Vorhees J.J. Application of retinol to human skin in vivo induces epidermal hyperplasie and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J. Invest. Dermatol. 105:1995;549-556.